2seventy bio
Cambridge, US · Founded 2021 · Delaware corporation
Founders & leadership
NL
Nick LeschlyExecutive
PG
Philip GregoryExecutive
WD
William D. BairdExecutive
MV
Marcela V. MausNamed on SEC filing
WR
William R. SellersNamed on SEC filing
SJ
Sarah JS GlickmanNamed on SEC filing
RI
Ramy IbrahimNamed on SEC filing
DL
Daniel LynchNamed on SEC filing
NH
Nicola HeffronNamed on SEC filing
Board
DT
Denice TorresBoard director
Reported raises · per SEC filings
Form D private placements$170M disclosed across 1 round · 2022
▶$170MraisedMar 2022 · 22 investors · BiotechnologyRule 506(b)
▶$170MraisedMar 2022 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Marcela V. MausDirector
- Denice TorresDirector
- Nick LeschlyExecutive Officer, Director
- Philip GregoryExecutive Officer
- William R. SellersDirector
- William D. BairdExecutive Officer
- Sarah JS GlickmanDirector
- Ramy IbrahimDirector
- Daniel LynchDirector
- Nicola HeffronExecutive Officer
- Offering amount
- $170M
- Amount sold
- $170M
- Sales commissions
- $3.8M
- Placement agents
- Goldman Sachs & Co. LLC
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has 2seventy bio raised?
- 2seventy bio has disclosed $170M raised across 1 round.
- Where is 2seventy bio headquartered?
- 2seventy bio is headquartered in Cambridge, US.